nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—Risedronate—osteoporosis	0.551	1	CbGbCtD
Ketorolac—Fatigue—Ethinyl Estradiol—osteoporosis	0.000203	0.000454	CcSEcCtD
Ketorolac—Pruritus—Alendronate—osteoporosis	0.000202	0.000453	CcSEcCtD
Ketorolac—Dyspepsia—Risedronate—osteoporosis	0.000202	0.000452	CcSEcCtD
Ketorolac—Eye disorder—Estradiol—osteoporosis	0.000202	0.000452	CcSEcCtD
Ketorolac—Tinnitus—Estradiol—osteoporosis	0.000201	0.000451	CcSEcCtD
Ketorolac—Constipation—Ethinyl Estradiol—osteoporosis	0.000201	0.00045	CcSEcCtD
Ketorolac—Confusional state—Zoledronate—osteoporosis	0.000201	0.000449	CcSEcCtD
Ketorolac—Hypersensitivity—Calcitriol—osteoporosis	0.0002	0.000449	CcSEcCtD
Ketorolac—Flushing—Estradiol—osteoporosis	0.0002	0.000449	CcSEcCtD
Ketorolac—Cardiac disorder—Estradiol—osteoporosis	0.0002	0.000449	CcSEcCtD
Ketorolac—Chest pain—Conjugated Estrogens—osteoporosis	0.0002	0.000448	CcSEcCtD
Ketorolac—Arthralgia—Conjugated Estrogens—osteoporosis	0.0002	0.000448	CcSEcCtD
Ketorolac—Myalgia—Conjugated Estrogens—osteoporosis	0.0002	0.000448	CcSEcCtD
Ketorolac—Asthenia—Ibandronate—osteoporosis	0.000199	0.000447	CcSEcCtD
Ketorolac—Anxiety—Conjugated Estrogens—osteoporosis	0.000199	0.000446	CcSEcCtD
Ketorolac—Nausea—Etidronic acid—osteoporosis	0.000199	0.000446	CcSEcCtD
Ketorolac—Oedema—Zoledronate—osteoporosis	0.000199	0.000446	CcSEcCtD
Ketorolac—Anaphylactic shock—Zoledronate—osteoporosis	0.000199	0.000446	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000198	0.000445	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000198	0.000445	CcSEcCtD
Ketorolac—Diarrhoea—Estropipate—osteoporosis	0.000198	0.000444	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Risedronate—osteoporosis	0.000198	0.000443	CcSEcCtD
Ketorolac—Infection—Zoledronate—osteoporosis	0.000198	0.000443	CcSEcCtD
Ketorolac—Fatigue—Risedronate—osteoporosis	0.000197	0.000443	CcSEcCtD
Ketorolac—Insomnia—Pamidronate—osteoporosis	0.000197	0.000441	CcSEcCtD
Ketorolac—Pruritus—Ibandronate—osteoporosis	0.000197	0.000441	CcSEcCtD
Ketorolac—Pain—Risedronate—osteoporosis	0.000196	0.000439	CcSEcCtD
Ketorolac—Constipation—Risedronate—osteoporosis	0.000196	0.000439	CcSEcCtD
Ketorolac—Angiopathy—Estradiol—osteoporosis	0.000196	0.000439	CcSEcCtD
Ketorolac—Shock—Zoledronate—osteoporosis	0.000196	0.000439	CcSEcCtD
Ketorolac—Paraesthesia—Pamidronate—osteoporosis	0.000196	0.000438	CcSEcCtD
Ketorolac—Diarrhoea—Alendronate—osteoporosis	0.000195	0.000438	CcSEcCtD
Ketorolac—Asthenia—Calcitriol—osteoporosis	0.000195	0.000437	CcSEcCtD
Ketorolac—Nervous system disorder—Zoledronate—osteoporosis	0.000195	0.000437	CcSEcCtD
Ketorolac—Immune system disorder—Estradiol—osteoporosis	0.000195	0.000437	CcSEcCtD
Ketorolac—Thrombocytopenia—Zoledronate—osteoporosis	0.000195	0.000436	CcSEcCtD
Ketorolac—Mediastinal disorder—Estradiol—osteoporosis	0.000194	0.000436	CcSEcCtD
Ketorolac—Dyspnoea—Pamidronate—osteoporosis	0.000194	0.000435	CcSEcCtD
Ketorolac—Tachycardia—Zoledronate—osteoporosis	0.000194	0.000435	CcSEcCtD
Ketorolac—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000194	0.000434	CcSEcCtD
Ketorolac—Chills—Estradiol—osteoporosis	0.000194	0.000434	CcSEcCtD
Ketorolac—Somnolence—Pamidronate—osteoporosis	0.000194	0.000434	CcSEcCtD
Ketorolac—Skin disorder—Zoledronate—osteoporosis	0.000193	0.000433	CcSEcCtD
Ketorolac—Pruritus—Calcitriol—osteoporosis	0.000193	0.000431	CcSEcCtD
Ketorolac—Hyperhidrosis—Zoledronate—osteoporosis	0.000192	0.000431	CcSEcCtD
Ketorolac—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000192	0.000431	CcSEcCtD
Ketorolac—Diarrhoea—Raloxifene—osteoporosis	0.000192	0.000431	CcSEcCtD
Ketorolac—Dyspepsia—Pamidronate—osteoporosis	0.000192	0.00043	CcSEcCtD
Ketorolac—Dizziness—Estropipate—osteoporosis	0.000192	0.00043	CcSEcCtD
Ketorolac—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000192	0.000429	CcSEcCtD
Ketorolac—Oedema—Conjugated Estrogens—osteoporosis	0.000192	0.000429	CcSEcCtD
Ketorolac—Alopecia—Estradiol—osteoporosis	0.000191	0.000427	CcSEcCtD
Ketorolac—Infection—Conjugated Estrogens—osteoporosis	0.00019	0.000426	CcSEcCtD
Ketorolac—Diarrhoea—Ibandronate—osteoporosis	0.00019	0.000426	CcSEcCtD
Ketorolac—Anorexia—Zoledronate—osteoporosis	0.00019	0.000425	CcSEcCtD
Ketorolac—Decreased appetite—Pamidronate—osteoporosis	0.000189	0.000424	CcSEcCtD
Ketorolac—Mental disorder—Estradiol—osteoporosis	0.000189	0.000424	CcSEcCtD
Ketorolac—Dizziness—Alendronate—osteoporosis	0.000189	0.000423	CcSEcCtD
Ketorolac—Shock—Conjugated Estrogens—osteoporosis	0.000188	0.000422	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000188	0.000421	CcSEcCtD
Ketorolac—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000188	0.000421	CcSEcCtD
Ketorolac—Malnutrition—Estradiol—osteoporosis	0.000188	0.000421	CcSEcCtD
Ketorolac—Erythema—Estradiol—osteoporosis	0.000188	0.000421	CcSEcCtD
Ketorolac—Fatigue—Pamidronate—osteoporosis	0.000188	0.000421	CcSEcCtD
Ketorolac—Gastrointestinal pain—Risedronate—osteoporosis	0.000187	0.00042	CcSEcCtD
Ketorolac—Tachycardia—Conjugated Estrogens—osteoporosis	0.000187	0.000419	CcSEcCtD
Ketorolac—Urticaria—Ethinyl Estradiol—osteoporosis	0.000187	0.000418	CcSEcCtD
Ketorolac—Pain—Pamidronate—osteoporosis	0.000186	0.000417	CcSEcCtD
Ketorolac—Constipation—Pamidronate—osteoporosis	0.000186	0.000417	CcSEcCtD
Ketorolac—Diarrhoea—Calcitriol—osteoporosis	0.000186	0.000417	CcSEcCtD
Ketorolac—Skin disorder—Conjugated Estrogens—osteoporosis	0.000186	0.000417	CcSEcCtD
Ketorolac—Hypotension—Zoledronate—osteoporosis	0.000186	0.000417	CcSEcCtD
Ketorolac—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000186	0.000416	CcSEcCtD
Ketorolac—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000186	0.000416	CcSEcCtD
Ketorolac—Dizziness—Raloxifene—osteoporosis	0.000186	0.000416	CcSEcCtD
Ketorolac—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000185	0.000415	CcSEcCtD
Ketorolac—Flatulence—Estradiol—osteoporosis	0.000185	0.000415	CcSEcCtD
Ketorolac—Tension—Estradiol—osteoporosis	0.000184	0.000413	CcSEcCtD
Ketorolac—Vomiting—Estropipate—osteoporosis	0.000184	0.000413	CcSEcCtD
Ketorolac—Dysgeusia—Estradiol—osteoporosis	0.000184	0.000412	CcSEcCtD
Ketorolac—Dizziness—Ibandronate—osteoporosis	0.000184	0.000412	CcSEcCtD
Ketorolac—Rash—Estropipate—osteoporosis	0.000183	0.00041	CcSEcCtD
Ketorolac—Dermatitis—Estropipate—osteoporosis	0.000183	0.000409	CcSEcCtD
Ketorolac—Anorexia—Conjugated Estrogens—osteoporosis	0.000183	0.000409	CcSEcCtD
Ketorolac—Nervousness—Estradiol—osteoporosis	0.000182	0.000409	CcSEcCtD
Ketorolac—Urticaria—Risedronate—osteoporosis	0.000182	0.000408	CcSEcCtD
Ketorolac—Back pain—Estradiol—osteoporosis	0.000182	0.000407	CcSEcCtD
Ketorolac—Headache—Estropipate—osteoporosis	0.000182	0.000407	CcSEcCtD
Ketorolac—Vomiting—Alendronate—osteoporosis	0.000182	0.000407	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000181	0.000406	CcSEcCtD
Ketorolac—Abdominal pain—Risedronate—osteoporosis	0.000181	0.000406	CcSEcCtD
Ketorolac—Body temperature increased—Risedronate—osteoporosis	0.000181	0.000406	CcSEcCtD
Ketorolac—Rash—Alendronate—osteoporosis	0.00018	0.000403	CcSEcCtD
Ketorolac—Insomnia—Zoledronate—osteoporosis	0.00018	0.000403	CcSEcCtD
Ketorolac—Dermatitis—Alendronate—osteoporosis	0.00018	0.000403	CcSEcCtD
Ketorolac—Feeling abnormal—Pamidronate—osteoporosis	0.000179	0.000402	CcSEcCtD
Ketorolac—Hypotension—Conjugated Estrogens—osteoporosis	0.000179	0.000401	CcSEcCtD
Ketorolac—Headache—Alendronate—osteoporosis	0.000179	0.000401	CcSEcCtD
Ketorolac—Paraesthesia—Zoledronate—osteoporosis	0.000179	0.0004	CcSEcCtD
Ketorolac—Vomiting—Raloxifene—osteoporosis	0.000179	0.0004	CcSEcCtD
Ketorolac—Gastrointestinal pain—Pamidronate—osteoporosis	0.000178	0.000399	CcSEcCtD
Ketorolac—Dyspnoea—Zoledronate—osteoporosis	0.000177	0.000397	CcSEcCtD
Ketorolac—Rash—Raloxifene—osteoporosis	0.000177	0.000397	CcSEcCtD
Ketorolac—Dermatitis—Raloxifene—osteoporosis	0.000177	0.000396	CcSEcCtD
Ketorolac—Somnolence—Zoledronate—osteoporosis	0.000177	0.000396	CcSEcCtD
Ketorolac—Vomiting—Ibandronate—osteoporosis	0.000177	0.000396	CcSEcCtD
Ketorolac—Tremor—Estradiol—osteoporosis	0.000176	0.000394	CcSEcCtD
Ketorolac—Headache—Raloxifene—osteoporosis	0.000176	0.000394	CcSEcCtD
Ketorolac—Rash—Ibandronate—osteoporosis	0.000175	0.000393	CcSEcCtD
Ketorolac—Dermatitis—Ibandronate—osteoporosis	0.000175	0.000392	CcSEcCtD
Ketorolac—Dyspepsia—Zoledronate—osteoporosis	0.000175	0.000392	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000174	0.000391	CcSEcCtD
Ketorolac—Ill-defined disorder—Estradiol—osteoporosis	0.000174	0.000391	CcSEcCtD
Ketorolac—Headache—Ibandronate—osteoporosis	0.000174	0.00039	CcSEcCtD
Ketorolac—Insomnia—Conjugated Estrogens—osteoporosis	0.000173	0.000388	CcSEcCtD
Ketorolac—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000173	0.000388	CcSEcCtD
Ketorolac—Vomiting—Calcitriol—osteoporosis	0.000173	0.000388	CcSEcCtD
Ketorolac—Decreased appetite—Zoledronate—osteoporosis	0.000173	0.000387	CcSEcCtD
Ketorolac—Agitation—Estradiol—osteoporosis	0.000173	0.000387	CcSEcCtD
Ketorolac—Nausea—Estropipate—osteoporosis	0.000172	0.000386	CcSEcCtD
Ketorolac—Abdominal pain—Pamidronate—osteoporosis	0.000172	0.000386	CcSEcCtD
Ketorolac—Body temperature increased—Pamidronate—osteoporosis	0.000172	0.000386	CcSEcCtD
Ketorolac—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000172	0.000385	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000172	0.000385	CcSEcCtD
Ketorolac—Angioedema—Estradiol—osteoporosis	0.000172	0.000385	CcSEcCtD
Ketorolac—Rash—Calcitriol—osteoporosis	0.000172	0.000384	CcSEcCtD
Ketorolac—Fatigue—Zoledronate—osteoporosis	0.000171	0.000384	CcSEcCtD
Ketorolac—Dermatitis—Calcitriol—osteoporosis	0.000171	0.000384	CcSEcCtD
Ketorolac—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000171	0.000383	CcSEcCtD
Ketorolac—Headache—Calcitriol—osteoporosis	0.00017	0.000382	CcSEcCtD
Ketorolac—Somnolence—Conjugated Estrogens—osteoporosis	0.00017	0.000382	CcSEcCtD
Ketorolac—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.00017	0.0742	CbGpPWpGaD
Ketorolac—Pain—Zoledronate—osteoporosis	0.00017	0.000381	CcSEcCtD
Ketorolac—Constipation—Zoledronate—osteoporosis	0.00017	0.000381	CcSEcCtD
Ketorolac—Nausea—Alendronate—osteoporosis	0.00017	0.00038	CcSEcCtD
Ketorolac—Malaise—Estradiol—osteoporosis	0.000169	0.00038	CcSEcCtD
Ketorolac—Hypersensitivity—Risedronate—osteoporosis	0.000169	0.000378	CcSEcCtD
Ketorolac—Vertigo—Estradiol—osteoporosis	0.000169	0.000378	CcSEcCtD
Ketorolac—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000169	0.000378	CcSEcCtD
Ketorolac—Asthenia—Ethinyl Estradiol—osteoporosis	0.000169	0.000378	CcSEcCtD
Ketorolac—Syncope—Estradiol—osteoporosis	0.000168	0.000377	CcSEcCtD
Ketorolac—Nausea—Raloxifene—osteoporosis	0.000167	0.000374	CcSEcCtD
Ketorolac—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000166	0.000373	CcSEcCtD
Ketorolac—Pruritus—Ethinyl Estradiol—osteoporosis	0.000166	0.000373	CcSEcCtD
Ketorolac—Palpitations—Estradiol—osteoporosis	0.000166	0.000372	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000165	0.000371	CcSEcCtD
Ketorolac—Fatigue—Conjugated Estrogens—osteoporosis	0.000165	0.00037	CcSEcCtD
Ketorolac—Nausea—Ibandronate—osteoporosis	0.000165	0.00037	CcSEcCtD
Ketorolac—Loss of consciousness—Estradiol—osteoporosis	0.000165	0.00037	CcSEcCtD
Ketorolac—Asthenia—Risedronate—osteoporosis	0.000164	0.000368	CcSEcCtD
Ketorolac—Feeling abnormal—Zoledronate—osteoporosis	0.000164	0.000367	CcSEcCtD
Ketorolac—Cough—Estradiol—osteoporosis	0.000164	0.000367	CcSEcCtD
Ketorolac—Pain—Conjugated Estrogens—osteoporosis	0.000164	0.000367	CcSEcCtD
Ketorolac—Constipation—Conjugated Estrogens—osteoporosis	0.000164	0.000367	CcSEcCtD
Ketorolac—Gastrointestinal pain—Zoledronate—osteoporosis	0.000163	0.000364	CcSEcCtD
Ketorolac—Hypertension—Estradiol—osteoporosis	0.000162	0.000363	CcSEcCtD
Ketorolac—Pruritus—Risedronate—osteoporosis	0.000162	0.000363	CcSEcCtD
Ketorolac—Nausea—Calcitriol—osteoporosis	0.000162	0.000362	CcSEcCtD
Ketorolac—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000161	0.00036	CcSEcCtD
Ketorolac—Hypersensitivity—Pamidronate—osteoporosis	0.00016	0.00036	CcSEcCtD
Ketorolac—Arthralgia—Estradiol—osteoporosis	0.00016	0.000358	CcSEcCtD
Ketorolac—Chest pain—Estradiol—osteoporosis	0.00016	0.000358	CcSEcCtD
Ketorolac—Myalgia—Estradiol—osteoporosis	0.00016	0.000358	CcSEcCtD
Ketorolac—Anxiety—Estradiol—osteoporosis	0.000159	0.000357	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000159	0.000356	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000158	0.069	CbGpPWpGaD
Ketorolac—Urticaria—Zoledronate—osteoporosis	0.000158	0.000354	CcSEcCtD
Ketorolac—Discomfort—Estradiol—osteoporosis	0.000158	0.000354	CcSEcCtD
Ketorolac—Abdominal pain—Zoledronate—osteoporosis	0.000157	0.000352	CcSEcCtD
Ketorolac—Body temperature increased—Zoledronate—osteoporosis	0.000157	0.000352	CcSEcCtD
Ketorolac—Diarrhoea—Risedronate—osteoporosis	0.000157	0.000351	CcSEcCtD
Ketorolac—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000157	0.000351	CcSEcCtD
Ketorolac—Dry mouth—Estradiol—osteoporosis	0.000156	0.00035	CcSEcCtD
Ketorolac—Asthenia—Pamidronate—osteoporosis	0.000156	0.00035	CcSEcCtD
Ketorolac—Dizziness—Ethinyl Estradiol—osteoporosis	0.000155	0.000348	CcSEcCtD
Ketorolac—Confusional state—Estradiol—osteoporosis	0.000155	0.000346	CcSEcCtD
Ketorolac—Pruritus—Pamidronate—osteoporosis	0.000154	0.000345	CcSEcCtD
Ketorolac—Anaphylactic shock—Estradiol—osteoporosis	0.000153	0.000344	CcSEcCtD
Ketorolac—Oedema—Estradiol—osteoporosis	0.000153	0.000344	CcSEcCtD
Ketorolac—Infection—Estradiol—osteoporosis	0.000152	0.000341	CcSEcCtD
Ketorolac—Urticaria—Conjugated Estrogens—osteoporosis	0.000152	0.000341	CcSEcCtD
Ketorolac—Dizziness—Risedronate—osteoporosis	0.000151	0.000339	CcSEcCtD
Ketorolac—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000151	0.000339	CcSEcCtD
Ketorolac—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000151	0.000339	CcSEcCtD
Ketorolac—Shock—Estradiol—osteoporosis	0.000151	0.000338	CcSEcCtD
Ketorolac—Nervous system disorder—Estradiol—osteoporosis	0.00015	0.000337	CcSEcCtD
Ketorolac—Tachycardia—Estradiol—osteoporosis	0.00015	0.000335	CcSEcCtD
Ketorolac—Vomiting—Ethinyl Estradiol—osteoporosis	0.000149	0.000335	CcSEcCtD
Ketorolac—Diarrhoea—Pamidronate—osteoporosis	0.000149	0.000334	CcSEcCtD
Ketorolac—Skin disorder—Estradiol—osteoporosis	0.000149	0.000334	CcSEcCtD
Ketorolac—Hyperhidrosis—Estradiol—osteoporosis	0.000148	0.000332	CcSEcCtD
Ketorolac—Rash—Ethinyl Estradiol—osteoporosis	0.000148	0.000332	CcSEcCtD
Ketorolac—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000148	0.000332	CcSEcCtD
Ketorolac—Headache—Ethinyl Estradiol—osteoporosis	0.000147	0.00033	CcSEcCtD
Ketorolac—Hypersensitivity—Zoledronate—osteoporosis	0.000147	0.000328	CcSEcCtD
Ketorolac—Vomiting—Risedronate—osteoporosis	0.000146	0.000326	CcSEcCtD
Ketorolac—Rash—Risedronate—osteoporosis	0.000144	0.000324	CcSEcCtD
Ketorolac—Dermatitis—Risedronate—osteoporosis	0.000144	0.000323	CcSEcCtD
Ketorolac—Dizziness—Pamidronate—osteoporosis	0.000144	0.000323	CcSEcCtD
Ketorolac—Headache—Risedronate—osteoporosis	0.000144	0.000322	CcSEcCtD
Ketorolac—Asthenia—Zoledronate—osteoporosis	0.000143	0.00032	CcSEcCtD
Ketorolac—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000141	0.000316	CcSEcCtD
Ketorolac—Pruritus—Zoledronate—osteoporosis	0.000141	0.000315	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00014	0.000313	CcSEcCtD
Ketorolac—Nausea—Ethinyl Estradiol—osteoporosis	0.00014	0.000313	CcSEcCtD
Ketorolac—Insomnia—Estradiol—osteoporosis	0.000139	0.000311	CcSEcCtD
Ketorolac—Vomiting—Pamidronate—osteoporosis	0.000138	0.00031	CcSEcCtD
Ketorolac—Paraesthesia—Estradiol—osteoporosis	0.000138	0.000308	CcSEcCtD
Ketorolac—Asthenia—Conjugated Estrogens—osteoporosis	0.000137	0.000308	CcSEcCtD
Ketorolac—Rash—Pamidronate—osteoporosis	0.000137	0.000308	CcSEcCtD
Ketorolac—Dermatitis—Pamidronate—osteoporosis	0.000137	0.000307	CcSEcCtD
Ketorolac—Dyspnoea—Estradiol—osteoporosis	0.000137	0.000306	CcSEcCtD
Ketorolac—Headache—Pamidronate—osteoporosis	0.000136	0.000306	CcSEcCtD
Ketorolac—Somnolence—Estradiol—osteoporosis	0.000136	0.000305	CcSEcCtD
Ketorolac—Diarrhoea—Zoledronate—osteoporosis	0.000136	0.000305	CcSEcCtD
Ketorolac—Nausea—Risedronate—osteoporosis	0.000136	0.000305	CcSEcCtD
Ketorolac—Pruritus—Conjugated Estrogens—osteoporosis	0.000136	0.000304	CcSEcCtD
Ketorolac—Dyspepsia—Estradiol—osteoporosis	0.000135	0.000302	CcSEcCtD
Ketorolac—Decreased appetite—Estradiol—osteoporosis	0.000133	0.000299	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Estradiol—osteoporosis	0.000132	0.000297	CcSEcCtD
Ketorolac—Fatigue—Estradiol—osteoporosis	0.000132	0.000296	CcSEcCtD
Ketorolac—Dizziness—Zoledronate—osteoporosis	0.000132	0.000295	CcSEcCtD
Ketorolac—Pain—Estradiol—osteoporosis	0.000131	0.000294	CcSEcCtD
Ketorolac—Constipation—Estradiol—osteoporosis	0.000131	0.000294	CcSEcCtD
Ketorolac—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000131	0.000294	CcSEcCtD
Ketorolac—Nausea—Pamidronate—osteoporosis	0.000129	0.00029	CcSEcCtD
Ketorolac—Dizziness—Conjugated Estrogens—osteoporosis	0.000127	0.000284	CcSEcCtD
Ketorolac—Vomiting—Zoledronate—osteoporosis	0.000126	0.000283	CcSEcCtD
Ketorolac—Feeling abnormal—Estradiol—osteoporosis	0.000126	0.000283	CcSEcCtD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000126	0.0548	CbGpPWpGaD
Ketorolac—Rash—Zoledronate—osteoporosis	0.000125	0.000281	CcSEcCtD
Ketorolac—Gastrointestinal pain—Estradiol—osteoporosis	0.000125	0.000281	CcSEcCtD
Ketorolac—Dermatitis—Zoledronate—osteoporosis	0.000125	0.000281	CcSEcCtD
Ketorolac—Headache—Zoledronate—osteoporosis	0.000125	0.000279	CcSEcCtD
Ketorolac—Vomiting—Conjugated Estrogens—osteoporosis	0.000122	0.000273	CcSEcCtD
Ketorolac—Urticaria—Estradiol—osteoporosis	0.000122	0.000273	CcSEcCtD
Ketorolac—Body temperature increased—Estradiol—osteoporosis	0.000121	0.000272	CcSEcCtD
Ketorolac—Abdominal pain—Estradiol—osteoporosis	0.000121	0.000272	CcSEcCtD
Ketorolac—Rash—Conjugated Estrogens—osteoporosis	0.000121	0.000271	CcSEcCtD
Ketorolac—Dermatitis—Conjugated Estrogens—osteoporosis	0.000121	0.00027	CcSEcCtD
Ketorolac—Headache—Conjugated Estrogens—osteoporosis	0.00012	0.000269	CcSEcCtD
Ketorolac—Nausea—Zoledronate—osteoporosis	0.000118	0.000265	CcSEcCtD
Ketorolac—Nausea—Conjugated Estrogens—osteoporosis	0.000114	0.000255	CcSEcCtD
Ketorolac—Hypersensitivity—Estradiol—osteoporosis	0.000113	0.000253	CcSEcCtD
Ketorolac—Asthenia—Estradiol—osteoporosis	0.00011	0.000246	CcSEcCtD
Ketorolac—Pruritus—Estradiol—osteoporosis	0.000108	0.000243	CcSEcCtD
Ketorolac—Diarrhoea—Estradiol—osteoporosis	0.000105	0.000235	CcSEcCtD
Ketorolac—Dizziness—Estradiol—osteoporosis	0.000101	0.000227	CcSEcCtD
Ketorolac—Vomiting—Estradiol—osteoporosis	9.75e-05	0.000218	CcSEcCtD
Ketorolac—Rash—Estradiol—osteoporosis	9.67e-05	0.000217	CcSEcCtD
Ketorolac—Dermatitis—Estradiol—osteoporosis	9.66e-05	0.000216	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	9.65e-05	0.0421	CbGpPWpGaD
Ketorolac—Headache—Estradiol—osteoporosis	9.6e-05	0.000215	CcSEcCtD
Ketorolac—Nausea—Estradiol—osteoporosis	9.11e-05	0.000204	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	8.95e-05	0.039	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	7.66e-05	0.0334	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.44e-05	0.0281	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	5.79e-05	0.0252	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	4.56e-05	0.0199	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	4.02e-05	0.0175	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	3.93e-05	0.0171	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	3.65e-05	0.0159	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP27A1—osteoporosis	3.42e-05	0.0149	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	3.41e-05	0.0149	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	3.39e-05	0.0148	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.38e-05	0.0148	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	3.12e-05	0.0136	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	2.74e-05	0.0119	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	2.73e-05	0.0119	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	2.69e-05	0.0117	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	2.62e-05	0.0114	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	2.5e-05	0.0109	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	2.31e-05	0.0101	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.29e-05	0.00997	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	2.17e-05	0.00947	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.17e-05	0.00946	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	2.08e-05	0.00908	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.03e-05	0.00887	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.03e-05	0.00885	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	1.99e-05	0.00866	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	1.85e-05	0.00806	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	1.83e-05	0.00799	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.82e-05	0.00792	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP19A1—osteoporosis	1.8e-05	0.00784	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.72e-05	0.00751	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.69e-05	0.00735	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.64e-05	0.00717	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.44e-05	0.0063	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.42e-05	0.00621	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	1.37e-05	0.00597	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—LEP—osteoporosis	1.35e-05	0.00588	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.34e-05	0.00584	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.33e-05	0.00578	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.31e-05	0.00573	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.3e-05	0.00569	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.24e-05	0.00541	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.12e-05	0.00487	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.09e-05	0.00474	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—POMC—osteoporosis	1.08e-05	0.00471	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.04e-05	0.00455	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FDPS—osteoporosis	1.02e-05	0.00444	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PKM—osteoporosis	1.02e-05	0.00444	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	9.94e-06	0.00434	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GPD2—osteoporosis	9.66e-06	0.00421	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PGLS—osteoporosis	9.66e-06	0.00421	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PKM—osteoporosis	9.66e-06	0.00421	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SOST—osteoporosis	9.66e-06	0.00421	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PGLS—osteoporosis	9.15e-06	0.00399	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ANTXR2—osteoporosis	9.15e-06	0.00399	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.87e-06	0.00387	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PNP—osteoporosis	8.83e-06	0.00385	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ATIC—osteoporosis	8.83e-06	0.00385	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	8.79e-06	0.00383	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.76e-06	0.00382	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	8.6e-06	0.00375	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FDPS—osteoporosis	8.09e-06	0.00353	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PKM—osteoporosis	8.09e-06	0.00353	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	8.02e-06	0.0035	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	7.89e-06	0.00344	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GSN—osteoporosis	7.78e-06	0.00339	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PGLS—osteoporosis	7.67e-06	0.00334	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPD2—osteoporosis	7.67e-06	0.00334	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.58e-06	0.00331	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA2—osteoporosis	7.51e-06	0.00327	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—OXCT1—osteoporosis	7.51e-06	0.00327	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MGLL—osteoporosis	7.32e-06	0.00319	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ATIC—osteoporosis	7.01e-06	0.00306	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PNP—osteoporosis	7.01e-06	0.00306	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.9e-06	0.00301	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LRP5—osteoporosis	6.77e-06	0.00295	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—osteoporosis	6.7e-06	0.00292	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	6.68e-06	0.00291	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LRP6—osteoporosis	6.48e-06	0.00282	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	6.37e-06	0.00278	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—osteoporosis	6.24e-06	0.00272	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH2—osteoporosis	6.22e-06	0.00271	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL24—osteoporosis	6.22e-06	0.00271	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LTF—osteoporosis	6.22e-06	0.00271	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—OXCT1—osteoporosis	5.96e-06	0.0026	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA2—osteoporosis	5.96e-06	0.0026	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP27A1—osteoporosis	5.85e-06	0.00255	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MGLL—osteoporosis	5.81e-06	0.00253	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ACP5—osteoporosis	5.69e-06	0.00248	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.62e-06	0.00245	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.48e-06	0.00239	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ACP5—osteoporosis	5.39e-06	0.00235	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TPI1—osteoporosis	5.29e-06	0.00231	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—osteoporosis	5.04e-06	0.0022	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TPI1—osteoporosis	5.02e-06	0.00219	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—P4HB—osteoporosis	4.97e-06	0.00217	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH2—osteoporosis	4.94e-06	0.00215	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GAPDH—osteoporosis	4.88e-06	0.00213	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RAP1A—osteoporosis	4.76e-06	0.00207	CbGpPWpGaD
Ketorolac—PTGS2—Disease—P4HB—osteoporosis	4.72e-06	0.00206	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP27A1—osteoporosis	4.64e-06	0.00203	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GAPDH—osteoporosis	4.63e-06	0.00202	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.56e-06	0.00199	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.55e-06	0.00198	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACP5—osteoporosis	4.52e-06	0.00197	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.46e-06	0.00195	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NFATC1—osteoporosis	4.4e-06	0.00192	CbGpPWpGaD
Ketorolac—PTGS2—Disease—DKK1—osteoporosis	4.36e-06	0.0019	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.25e-06	0.00185	CbGpPWpGaD
Ketorolac—PTGS2—Disease—WNT1—osteoporosis	4.2e-06	0.00183	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TPI1—osteoporosis	4.2e-06	0.00183	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.15e-06	0.00181	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGA—osteoporosis	4.09e-06	0.00178	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—P4HB—osteoporosis	3.95e-06	0.00172	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GAPDH—osteoporosis	3.88e-06	0.00169	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO1—osteoporosis	3.84e-06	0.00168	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSMA5—osteoporosis	3.79e-06	0.00165	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSMA2—osteoporosis	3.79e-06	0.00165	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RAP1A—osteoporosis	3.78e-06	0.00165	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ENO1—osteoporosis	3.64e-06	0.00159	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSMA5—osteoporosis	3.59e-06	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSMA2—osteoporosis	3.59e-06	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CALCA—osteoporosis	3.35e-06	0.00146	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.29e-06	0.00144	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP19A1—osteoporosis	3.07e-06	0.00134	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO1—osteoporosis	3.05e-06	0.00133	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KL—osteoporosis	3.04e-06	0.00133	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSMA5—osteoporosis	3.01e-06	0.00131	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSMA2—osteoporosis	3.01e-06	0.00131	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADCY5—osteoporosis	2.51e-06	0.0011	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GPX1—osteoporosis	2.5e-06	0.00109	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP19A1—osteoporosis	2.44e-06	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ADCY5—osteoporosis	2.38e-06	0.00104	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—osteoporosis	2.31e-06	0.00101	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—osteoporosis	2.19e-06	0.000955	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS2—osteoporosis	2.08e-06	0.000908	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADCY5—osteoporosis	1.99e-06	0.000869	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GPX1—osteoporosis	1.99e-06	0.000866	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—POMC—osteoporosis	1.85e-06	0.000805	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—osteoporosis	1.83e-06	0.0008	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS1—osteoporosis	1.82e-06	0.000793	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6R—osteoporosis	1.71e-06	0.000745	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—POMC—osteoporosis	1.47e-06	0.000639	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—osteoporosis	1.01e-06	0.000441	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—osteoporosis	1.01e-06	0.00044	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—osteoporosis	7.61e-07	0.000332	CbGpPWpGaD
